AGI Glaspac

Sector: Packaging, Glass Containers  |  HQ: Hyderabad, Telangana, India  |  Founded: 1981  |  Employees: 2,500+

Listed as: NSE / BSE listed (HSIL)  |  NSE / BSE  |  Ticker: HSIL.NS

Company overview

AGI Glaspac is the container glass manufacturing division of AGI Greenpac Limited (NSE: AGI, BSE: 500189, formerly HSIL Limited). The business is among India's largest container glass manufacturers, serving the alcoholic beverage, pharmaceuticals, food and beverage, cosmetics, and personal care industries with glass bottles, vials, and containers. AGI Glaspac operates manufacturing facilities at Bhongir (Telangana, the historic Hyderabad-region plant) and Kandanga (Tamil Nadu, the Bhongir expansion), with combined glass melting capacity of approximately 1,500 tonnes per day. AGI Greenpac was created in 2022 through the demerger of HSIL Limited (Hindustan Sanitaryware and Industries Limited) into two separate entities. AGI Greenpac retained the packaging products business including AGI Glaspac (container glass) and AGI Speciality Glass (decorative and pharmaceutical specialty glass), while Brilloca Limited (now under Hindware) retained the building products business (sanitaryware, faucets, plastic pipes). AGI Greenpac is part of the broader Somany Group's promoter family interest, distinct from H&R Johnson Tiles and Somany Ceramics which are separate group entities.

Financial performance and recent trajectory

Disclosed revenue (FY25): ₹2,200 crore (FY 2024-25 estimate, AGI Greenpac consolidated).

Competitive position

AGI Glaspac is one of the top three Indian container glass manufacturers alongside Hindusthan National Glass and Industries (HNGI, formerly the market leader, currently in NCLT resolution), Piramal Glass (owned by Blackstone since 2020 after acquisition from Piramal Enterprises), and Borosil Limited (NSE: BORO, focused on consumer and scientific glass rather than mass container glass). In the alcoholic beverage glass bottle segment specifically, AGI is among the top two suppliers along with HNGI to the major Indian liquor companies (United Breweries, AB InBev, United Spirits, Pernod Ricard India, Radico Khaitan, Allied Blenders and Distillers). In pharmaceutical glass vials and ampoules, the segment is more specialised with players including Schott Kaisha (Indian arm of German Schott), SGD Pharma India, Stevanato Group India, and AGI Speciality Glass. The competitive moats are the scale of the Bhongir and Kandanga plants, the technology partnerships for furnace and forming equipment (Emhart Glass, GPS-Glass Service), the long-standing customer relationships with major liquor and pharma OEMs, and the captive cullet (recycled glass) sourcing infrastructure. The principal vulnerabilities are energy cost volatility (glass furnaces are energy-intensive), competitive intensity from HNGI emerging from insolvency under a new buyer, structural shift of alcoholic beverages toward aluminium cans and PET bottles, and Piramal Glass's potential operational ramp-up under Blackstone ownership.

Key risks

Natural gas and fuel oil cost volatility affecting furnace economics Structural shift of alcoholic beverages toward aluminium cans and PET HNG Industries restructuring outcome reshaping competitive landscape

Outlook

AGI Glaspac was originally established as Associated Glass Industries Limited in 1981 in Bhongir, Telangana. The company was acquired by HSIL Limited (Hindustan Sanitaryware and Industries Limited, the parent of the Hindware sanitaryware brand) in the early 2000s, becoming a packaging products business within the HSIL group. In 2022 HSIL Limited undertook a demerger into two listed entities: AGI Greenpac Limited (retaining packaging products including AGI Glaspac and AGI Speciality Glass) and Brilloca Limited (retaining the building products business). AGI Greenpac is currently listed under the symbol AGI on the NSE and BSE. The business is organised across two operating segments. The Container Glass segment, operated under AGI Glaspac, is the largest contributor and manufactures glass bottles, jars, and containers for alcoholic beverages (the largest customer segment), pharmaceuticals, food and beverages (jam, sauce, soft drink), cosmetics, and personal care. The Speciality Glass segment, operated under AGI Speciality Glass, manufactures pharmaceutical glass vials, ampoules, and decorative glass products, supported by select international collaborations and indigenous R&D. Manufacturing footprint includes two principal sites. The Bhongir plant in Telangana, the historic AGI flagship, has combined glass melting capacity across multiple furnaces. The Kandanga plant in Tamil Nadu, commissioned to expand southern India capacity and reduce logistics cost to Tamil Nadu and Karnataka customers, adds significant melting capacity. Combined daily melting capacity is approximately 1,500 tonnes per day across the two plants. Glass forming machines are supplied by Emhart Glass (now part of Glaston) and other global OEMs. Furnace technology is principally regenerative end-fired furnaces optimised for fuel efficiency and durability. Product portfolio includes flint (clear), amber (for UV-sensitive contents like beer and pharmaceuticals), green (for select food and pharma), and specialty colors. Bottle sizes range from 50 ml miniatures (for spirits) through 300 ml beer bottles, 650 ml beer bottles, 750 ml wine and spirits, and larger formats for industrial use. Pharma vials cover Type I, II, and III glass per the Indian Pharmacopoeia and US Pharmacopoeia specifications. Distribution and customer engagement is direct sale to major OEM customers under long-term supply agreements. The alcoholic beverage segment is the dominant customer pool: United Breweries (Heineken-controlled), AB InBev India, Carlsberg India, Mohan Meakin, United Spirits (Diageo-controlled), Pernod Ricard India, Radico Khaitan, Allied Blenders and Distillers (NSE listed in 2024), Tilaknagar Industries, and Globus Spirits. Pharmaceutical customers include the major Indian pharma manufacturers (Sun Pharma, Cipla, Dr Reddy's, Aurobindo Pharma, Lupin) and select international customers through specialty vial supply. Food and beverage customers include Hindustan Unilever, ITC, Nestle India, and various FMCG firms. Financial trajectory has been volatile through the FY22 to FY25 cycle. AGI Greenpac (post-demerger consolidated) revenue grew from approximately ₹1,650 crore in FY23 to ₹2,000 crore in FY24 and approximately ₹2,200 crore in FY25. EBITDA margin has ranged between 15 and 22 percent depending on energy cost (natural gas and fuel oil are major input lines), product mix (premium alcoholic beverage and pharma carry higher margin than commodity food and beverage), and capacity utilisation. The 2022 demerger and subsequent operational rationalisation has improved margin trajectory. Recent corporate development has included furnace rebuild and capacity expansion at Bhongir, capex for the speciality pharmaceutical glass segment to capture rising demand from Indian pharma exports, and progressive renewable energy procurement to reduce furnace fuel cost. The HNG Industries insolvency under NCLT resolution has been a meaningful competitive backdrop, with multiple resolution applicants (AGI Greenpac was itself one of the resolution applicants for HNG Industries' assets) bidding for the company's plants which would reshape the Indian container glass industry structure on completion. Strategy through 2025 to 2030 is anchored on four themes. First, capacity expansion through brownfield additions at Bhongir and Kandanga, and potentially the acquisition of HNG Industries assets out of NCLT resolution. Second, pharmaceutical specialty glass growth, where Indian pharma exports drive demand for Type I borosilicate vials and ampoules. Third, lightweighting and design innovation for premium alcoholic beverage customers, where bottle weight reduction supports both freight cost and ESG positioning. Fourth, energy transition with renewable electricity procurement and select pilots for hydrogen-fired or electric furnace technology for the long-term decarbonisation pathway. The regulatory environment includes the Bureau of Indian Standards specifications (IS 3030 for glass containers, IS 16077 for pharmaceutical vials), the Drugs and Cosmetics Act 1940 and Indian Pharmacopoeia specifications for pharma glass, the Food Safety and Standards Act 2006 for food contact materials, the Plastic Waste Management Rules 2016 (which favour glass as an alternative packaging material under Extended Producer Responsibility), and the Environment Protection Act 1986 for emissions compliance from glass furnaces. The Goods and Services Tax framework treats glass containers at 18 percent. The Companies Act 2013 and SEBI LODR govern listed company disclosure. Risks include energy cost volatility (natural gas pricing has been a major swing factor), HNG Industries restructuring outcome that may reshape the competitive landscape, structural shift of alcoholic beverages toward aluminium cans and PET, pharma export market regulatory changes affecting vial demand, currency exposure on imported furnace equipment and spares, and competitive intensity from imports particularly Chinese container glass at the lower end. Management quality is anchored by Sandeep Sikka as Managing Director with the Somany Group promoter family oversight. The board has a majority of independent directors with statutory audit by SRBC & Co LLP. Disclosure has improved post-demerger with focused packaging segment reporting. ESG positioning is structurally moderate. Glass is one of the few packaging materials that is infinitely recyclable, providing a circular economy benefit. The energy-intensive furnace operation is the principal challenge, with progressive renewable electricity procurement and cullet incorporation (recycled glass as input) as the abatement levers. AGI Glaspac reports BRSR disclosure under SEBI LODR.

KAMRIT point of view

Building or competing with AGI?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the packaging sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of AGI and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use AGI Glaspac in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.